Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRASG12C mutations.

Krazati (adagrasib) - BMS

Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRASG12C mutations. (PubMed, Future Oncol) - Sep 17, 2026 - No abstract available
Journal • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS

http://www.ncbi.nlm.nih.gov/pubmed/42745627

; Aitor Azkárate Martínez; Beata Korytowsky; Charlotte De Bondt; Enriqueta Felip; Fabrice Barlesi; Filippo DE Marinis; Giuseppe Lo Russo; Helena Linardou; Julie N Meade; Ludovic Doucet; Martin Reck; Mary F Michenzie; Michaël Duruisseaux; Óscar Juan-Vidal; Robert Jotte; Shun Lu; Tony S K Mok; Vanesa Gregorc; Wenjing Yang; Wenxiu Yao; Young-Chul Kim

Sep 17, 2026